Technical analysis provides insights that fundamental observations cannot. We can use that to our advantage in Acorda Therapeutics (NASDAQ: ACOR). Using the data offered below we have a real-time example. Review The technical data for ACOR below, and the added value of technical analysis will become clearer. Trading plans are derived naturally from the technicals. This data is current, but it is not real time. If you want a real time update, or data on a different stock, please get one here Unlimited Real Time Reports .
Technical Summary
Term ? | Near | Mid | Long |
---|---|---|---|
Bias | Weak | Weak | Strong |
P1 | 0 | 0 | 3.78 |
P2 | 4.68 | 4.47 | 5.42 |
P3 | 4.91 | 4.85 | 7.28 |
Long Term Trading Plans for ACOR
April 2, 2021, 12:30 am ET
The Technical Summary and Trading Plans for ACOR help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this ACOR Report.
ACOR - (Long) Support Plan
The technical summary data tells us to buy ACOR near 3.78 with an upside target of 5.42. This data also tells us to set a stop loss @ 3.77 to protect against excessive loss in case the stock begins to move against the trade. 3.78 is the first level of support below 4.78 , and by rule, any test of support is a buy signal. In this case, support 3.78 would be being tested, so a buy signal would exist.
ACOR - (Short) Resistance Plan
The technical summary data is suggesting a short of ACOR as it gets near 5.42 with a downside target of 3.78. We should have a stop loss in place at 5.44though. 5.42 is the first level of resistance above 4.78, and by rule, any test of resistance is a short signal. In this case, if resistance 5.42 is being tested, so a short signal would exist.